Journal of Antimicrobial Chemotherapy (1992) 30, 791-802
© 1992 The British Society for Antimicrobial Chemotherapy
research-article |
Growth-rate-independent killing by ciprofloxacin of biofilm-derived Staphylococcus epidermidis evidence for cell-cycle dependency
aDepartment of Pharmacy, University of Manchester Oxford Road, Manchester M139 PL UK bPharmaceutical Sciences Institute, Aston University Aston Triangle, Birmingham B4 7ET, UK
Received 23 April 1992; returned 28 August 1992; accepted 28 August 1992
*Corresponding author
Cell culture methods that allow culture of Staphylococcus epidermidis biofilms at controlled growth rates were used to examine susceptibility to ciprofloxacin. Changes in biofilm susceptibility, dependent upon growth rate, were compared with those for suspended populations grown in a chemostat, and also for newly-formed daughter cells shed from the biofilm during its growth and development. Susceptibility increased for intact and resuspended biofilms, and also for planktonic cultures, with increases in growth rate. The dependence of susceptibility upon growth rate was greatest for slow growing cells (µ, 0·01–0·15/h). At any particular growth rate, biofilms appeared more susceptible than their planktonic counterparts. Newly-formed daughter cells were relatively tolerant to ciprofloxacin at all rates of growth. Lick of growth rate dependency for the newly-formed cells suggested a role for the cell-division cyde in determining resistance. This was confirmed by examining the susceptibility of S. epidermidis throughout batch cultures with cell division synchronized. Perfusion of various steady-state biofilms with ciprofloxacin demonstrated killing of the adherent population even at much reduced rates of growth.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  P. Sass and G. Bierbaum Lytic Activity of Recombinant Bacteriophage {phi}11 and {phi}12 Endolysins on Whole Cells and Biofilms of Staphylococcus aureus Appl. Envir. Microbiol., January 1, 2007; 73(1): 347 - 352. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Curtin, M. Cormican, G. Fleming, J. Keelehan, and E. Colleran Linezolid Compared with Eperezolid, Vancomycin, and Gentamicin in an In Vitro Model of Antimicrobial Lock Therapy for Staphylococcus epidermidis Central Venous Catheter-Related Biofilm Infections Antimicrob. Agents Chemother., October 1, 2003; 47(10): 3145 - 3148. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Donlan and J. W. Costerton Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms Clin. Microbiol. Rev., April 1, 2002; 15(2): 167 - 193. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. N. Anderl, M. J. Franklin, and P. S. Stewart Role of Antibiotic Penetration Limitation in Klebsiella pneumoniae Biofilm Resistance to Ampicillin and Ciprofloxacin Antimicrob. Agents Chemother., July 1, 2000; 44(7): 1818 - 1824. [Abstract] [Full Text]
|
|
|
|
 |
|
 T. Maira-Litran, D. G. Allison, and P. Gilbert An evaluation of the potential of the multiple antibiotic resistance operon (mar) and the multidrug efflux pump acrAB to moderate resistance towards ciprofloxacin in Escherichia coli biofilms J. Antimicrob. Chemother., June 1, 2000; 45(6): 789 - 795. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. S. Baillie and L. J. Douglas Effect of Growth Rate on Resistance of Candida albicans Biofilms to Antifungal Agents Antimicrob. Agents Chemother., August 1, 1998; 42(8): 1900 - 1905. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. Gilbert, J. Das, and I. Foley Biofilm Susceptibility to Antimicrobials Advances in Dental Research, April 1, 1997; 11(1): 160 - 167. [Abstract] [PDF]
|
|